來源:[1] Tempus宣布與Whitehawk Therapeutics合作推進生物標誌物驅動的腫瘤學研究 (https://finance.yahoo.com/news/tempus-announc ...)[2] Tempus宣布與Whitehawk Therapeutics合作推進生物標誌物驅動的腫瘤學研究 - Business Wire (https://vertexaisearch.cloud.google.com/groun ...)[3] Whitehawk Therapeutics股價在與Tempus AI合作後飆升 - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)